CaMISS

PUBLICACIONES RELACIONADAS

Publicaciones de los últimos cinco años

2024

  • Abbad-Gomez D; Domingo L; Comas M; Santiá P; Jansana A; Poblador B; Sanz T, Del Cura I, Ibañez B; Padilla M; Redondo M; Castells X; Sala M. Effect of comorbidity and multimorbidity on adherence to follow-up recommendations among long-term breast cancer survivors. Maturitas, 2024 Apr;182:107918. Doi: 10.1016/j.maturitas.2024.107918
  • Laza C, Niño de Guzmán E, Gea M, Plazas M, Posso M, Rué M, Castells X, Romá M. «For and against» factors influencing participation in personalized breastcancer screening programs: a qualitative systematic review until March 2022. Arch Public Health. 2024 Feb 22;82(1):23. Doi: 10.1186/s13690-024-01248-x. 
  • Jørgensen SF, Sagstad S, Louro J, Román M, Castells X, Hofvind S, Njor S.Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain. Breast Cancer Res Treat. 2024 Jan 29. Doi:10.1007/s10549-023-07219-0. Epub ahead of print. 
  • Giannoula A, Comas M, Castells X, Estupiñán-Romero F, Bernal-Delgado E, Sanz F, Sala M. Exploring long-term breast cancer survivors’ care trajectories using dynamic time warping-based unsupervised clustering. J Am Med Inform Assoc. 2024 Jan 8:ocad251. Doi: 10.1093/jamia/ocad251. Epub ahead of print. PMID: 38193340.

2023

  • Eriksson M, Román M, Gräwingholt A, Castells X, Nitrosi A, Pattacini P, Heywang-Köbrunner S, Rossie PG. European validation of an image-derived AI-based short-term risk model for individualized breast cancer screening—a nested case-control study. The Lancet Regional Health – Europe 2023. 100798. doi.org/10. 1016/j.lanepe.2023.
  • Louro J, Román M, Moshina N, Olstad CF, Larsen M, Sagstad S, Castells X, Hofvind S. Personalized Breast Cancer Screening: A Risk Prediction Model Based on Women Attending BreastScreen Norway. Cancers (Basel) 2023 Sep 12;15(18):4517. Doi: 10.3390/cancers15184517.
  • Miret C, Orive M, Sala M, García-Gutiérrez S, Sarasqueta C, Legarreta MJ, Redondo M, Rivero A, Castells X, Quintana JM, Garin O, Ferrer M; REDISSEC-CaMISS Group. Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after. Qual Life Res. 2023 Apr;32(4):989-1003. Doi: 10.1007/s11136-022-03327-4. 

2022

  • Tsuruda KM, Larsen M, Román M, Hofvind S. Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in Breast Screen Norway. Cancer 2022 Apr 1; 128(7): 1373-1380. Doi: 10.1002/CNCR.34078Pmid: 34931707
  • Leis A, Casadevall D, Albanell J, Posso M, Macià F, Castells X, Ramírez-Anguita JM, Martínez Roldán J, Furlong LI, Sanz F, Ronzano F, Mayer MA. Exploring the Association of Cancer and Depression in Electronic Health Records: Combining Encoded Diagnosis and Mining. JMIR Cancer. 2022 Jul 11;8(3):e39003. Doi: 10.2196/39003. 
  • Larroza A, Pérez-Benito FJ, Perez-Cortes JC, Román M, Pollán M, Pérez Gómez B, Salas-Trejo D, Casals M, Llobet R. Breast Dense Tissue Segmentation with Noisy Labels: A Hybrid Threshold-Based and Mask-Based Approach. Diagnostics (Basel) 2022 Jul 28; 12(8): 1822. Doi: 10.3390/diagnostic12081822. 
  • Bosch G, Posso M, Louro J, Roman M, Porta M, Castells X, Macià F. Impact of the COVID-19 pandemic on breast cancer screening indicators in a Spanish population-based program: a cohort study. Elife. 2022 Jun 10;11:e77434. Doi: 10.7554/eLife.77434. 
  • Perez-Leon D, Posso M, Louro J, Ejarque B, Arranz M, Arenas N, Maiques J, Martínez J, TsurudaMaciá F, Román M, Rodríguez-Arana A, Castells X, Alcántara R. Does the patient-assisted compression mode affect the mammography quality? A within woman randomized controlled trial. Eur Radiol. 2022 Nov;32(11):7470-7479. Doi: 10.1007/s00330-022-08834-z. 
  • Arenas N, Alcantara R, Posso M, Louro J, Perez-Leon D, Ejarque B, Arranz M, Maiques J, Castells X, Macià F, Román M, Rodríguez-Arana A. Comparison of technical parameters and women’s experience between self-compression and standard compression modes in mammography screening: a single-blind randomized clinical trial. Eur Radiol. 2022 Nov;32(11):7480-7487. Doi: 10.1007/s00330-022-08835-y. 
  • Lidia Blay; Anna Jansana; Javier Louro; Laia Domingo; Joan Francesc Julian; Xavier Castells; Maria Sala. Influence of surgical technique on complications,readmissions and clinical progress of breast cancer inwomen participating in screening programs. Revista de Senología y Patología Mamaria 2022;35:33-41. Doi: 10.1016/j.senol.2021.09.001
  • Roux A, Cholerton R, Sicsic J, Moumjid N, French DP, Giorgi Rossi P, Balleyguier C, Guindy M, Gilbert FJ, Burrion JB, Castells X, Ritchie D, Keatley D, Baron C, Delaloge S, de Montgolfier S. Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the «My Personal Breast Screening» (MyPeBS) randomised clinical trial. BMC Cancer. 2022 May 6;22(1):507. Doi: 10.1186/s12885-022-09484-6. 
  • García M, Redondo M, Zarcos I, Louro J, Rivas-Ruiz F, Téllez T, Pérez D, Medina Cano F, Machan K, Domingo L, Del Mar Vernet M, Padilla-Ruiz M, Castells X, Sala M. Impact of Detection Mode in a Large Cohort of Women Taking Part in a Breast Screening Program. Eur J Breast Health. 2022 Apr 1;18(2):182-189. Doi: 10.4274/ejbh.galenos.2022.2021-11-8. 
  • Canelo-Aybar C, Posso M, Montero N, Solà I, Saz-Parkinson Z, Duffy SW, Follmann M, Gräwingholt A, Giorgi Rossi P, Alonso-Coello P. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer.  Br J Cancer. 2022 Mar;126(4):673-688. 10.1038/s41416-021-01521-8.
  • Román M, Louro J, Posso M, Vidal C, Bargalló X, Vázquez I, Quintana M.J, Alcántara R, Saladié F, del Riego J, Peñalva L, Sala M, Castells X, on behalf of the BELE and IRIS Study Groups. Long-Term Risk of Breast Cancer after Diagnosis of Benign Breast Disease by Screening Mammography. Int. J. Environ. Res. Public Health. 2022; 19(5):2625. https://doi.org/10.3390/ijerph19052625
  • Santiá P, Jansana A, Del Cura I, Padilla-Ruiz M, Domingo L, Louro J, Comas M, Sanz T, Duarte-Salles T, Redondo M, Ibañez B, Prados-Torres A, Castells X, Sala M; SURBCAN Group. Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort. Breast Cancer Res Treat. 2022 Jun;193(2):455-465. Doi:10.1007/s10549-022-06563-x. 
  • Hernández-García M, Molina-Barceló A, Vanaclocha-Espi M, Zurriaga Ó, Pérez-Gómez B, Aragonés N, Amiano P, Altzibar JM, Castaño-Vinyals G, Sala M, Ederra M, Martín V, Gómez-Acebo I, Vidal C, Tardón A, Marcos-Gragera R, Pollán M, Kogevinas M, Salas D. Differences in breast cancer-risk factors between screen-detected and non-screen-detected cases (MCC-Spain study). Cancer Causes Control. 2022 Jan;33(1):125-136. Doi: 10.1007/s10552-021-01511-4. 
  • Jansana A, Domingo L, Ibañez B, Prados A, Del Cura I, Padilla-Ruiz M, Sanz T, Poblador B, Tamayo I, Gimeno A, Alberquilla A, Abizanda M, Comas M, Lanzuela M, Burgui R, Holgado AD, Duarte-Salles T, Moreno C, Louro J, Baquedano J, Molina C, Del Carmen Martinez M, Gorricho J, Redondo M, Castells X, Sala M. Use of health services among long-term breast cancer survivors in Spain: longitudinal study based on real-world data. J Cancer Surviv. 2022 Feb;16(1):132-141. Doi: 10.1007/s11764-021-01011-z. 
  • Posso M, Alcántara R, Vázquez I, Comerma L, Baré M, Louro J, Quintana MJ, Román M, Marcos-Gragera R, Vernet-Tomas M, Saladie F, Vidal C, Bargalló X, Peñalva L, Sala M, Castells X; BELE study group. Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening. Eur Radiol. 2022 Jan;32(1):621-629. Doi: 10.1007/s00330-021-08118-y. 

2021

  • Louro J, Román M, Posso M, Vázquez I, Saladié F, Rodriguez-Arana A, Quintana MJ, Domingo L, Baré M, Marcos-Gragera R, Vernet-Tomas M, Sala M, Castells X, and BELE and IRIS Study Groups. Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening. PLoS ONE. 2021, 16(3): e0248930. https://doi.org/10.1371/journal
  • Román M, Louro J, Posso M, Alcántara R, Peñalva L, Sala M, Del Riego J, Prieto M, Vidal C, Sánchez M, Bargalló X, Tusquets I, Castells X, on behalf of the BELE and IRIS study groups. Breast density, benign breast disease, and risk of breast cancer over time. Eur Radiol. 2021. Doi: 10.1007/s00330-020-07490-5. 
  • Pons-Rodríguez A, Martínez-Alonso M, Perestelo-Pérez L, Garcia M, Sala M, Rué M; en nombre del grupo InforMa. Elección informada en el cribado del cáncer de mama: el papel del nivel educativo [Informed choice in breast cancer screening: the role of education]. Gac Sanit. 2021 May-Jun;35(3):243-249. Doi: 10.1016/j.gaceta.2020.01.002.
  • Clotas C, Serral G, Vidal Garcia E, Puigpinós-Riera R; DAMA Cohort Group. Dietary changes and food habits: social and clinical determinants in a cohort of women diagnosed with breast cancer in Barcelona (DAMA cohort). Cancer Causes Control. 2021 Dec;32(12):1355-1364. Doi: 10.1007/s10552-021-01483-5. 
  • Jansana A, Poblador-Plou B, Gimeno-Miguel A, Lanzuela M, Prados-Torres A, Domingo L, Comas M, Sanz-Cuesta T, Del Cura-Gonzalez I, Ibañez B, Abizanda M, Duarte-Salles T, Padilla-Ruiz M, Redondo M, Castells X, Sala M; SURBCAN Group. Multimorbidity clusters among long-term breast cancer survivors in Spain: Results of the SURBCAN study. Int J Cancer. 2021 Nov 15;149(10):1755-1767. Doi: 10.1002/ijc.33736. 
  • Montero-Moraga JM, Posso M, Román M, Burón A, Sala M, Castells X, Macià F. Effect of an information leaflet on breast cancer screening participation: A cluster randomized controlled trial. BMC Public Health. 2021 Jul 3;21(1):1301. Doi: 10.1186/s12889-021-11360-0. 
  • Montero-Moraga JM, Posso M, Román M, Burón A, Sala M, Castells X, Macià F. Effect of an information leaflet on breast cancer screening participation: A cluster randomized controlled trial. BMC Public Health. 2021 Jul 3;21(1):1301. Doi:10.1186/s12889-021-11360-0 
  • Canelo-Aybar C, Ferreira D, Ballesteros M, Posso M, Montero N, Solà I, Saz-Parkinson Z, Lerda D, Rossi PG, Duffy S, Follmann M, Grawingholt A, Alonso-Coello P. Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: A systematic review for the European Commission Initiative on Breast Cancer. J Med Screen. 2021 Dec;28(4):389-404. Doi: 10.1177/0969141321993866. 
  • Vernet-Tomás M, Louro J, Román M, Saladié F, Posso M, Prieto M, Vázquez I, Baré M, Peñalva L, Vidal C, Bargalló X, Sánchez M, Ferrer J, A Espinàs J, Quintana MJ, Rodríguez-Arana A, Castells X; BELE study group. Risk of breast cancer two years after a benign biopsy depends on the mammographic feature prompting recall. Maturitas 2021 Feb;144:53-59. Doi: 10.1016/j.maturitas.2020.10.024. 
  • Gómez-Acebo I, Dierssen-Sotos T, Mirones M, Pérez-Gómez B, Guevara M, Amiano P, Sala M, Molina AJ, Alonso-Molero J, Moreno V, Suarez-Calleja C, Molina-Barceló A, Alguacil J, Marcos-Gragera R, Fernández-Ortiz M, Sanz-Guadarrama O, Castaño-Vinyals G, Gil-Majuelo L, Moreno-Iribas C, Aragonés N, Kogevinas M, Pollán M, Llorca J. Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study. Sci Rep. 2021 Mar 8;11(1):5375. Doi: 10.1038/s41598-021-84825-2. 
  • Canelo-Aybar C, Carrera L, Beltrán J, Posso M, Rigau D, Lebeau A, Gräwingholt A, Castells X, Langendam M, Pérez E, Giorgi Rossi P, Van Engen R, Parmelli E, Saz-Parkinson Z, Alonso-Coello P. Digital breast tomosynthesis compared to diagnostic mammographic projections (including magnification) among women recalled at screening mammography: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC). Cancer Med. 2021 Apr;10(7):2191-2204. Doi: 10.1002/cam4.3803. 
  • Giorgi Rossi P, Lebeau A, Canelo-Aybar C, Saz-Parkinson Z, Quinn C, Langendam M, Mcgarrigle H, Warman S, Rigau D, Alonso-Coello P, Broeders M, Graewingholt A, Posso M, Duffy S, Schünemann HJ; ECIBC Contributor Group. Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative. Br J Cancer. 2021 Apr;124(9):1503-1512. Doi: 10.1038/s41416-020-01247-z.
  • Padilla-Ruiz M, Zarcos-Pedrinaci I, Rivas-Ruiz F, Téllez T, García-Gutiérrez S, González N, Rivero A, Sarasqueta C, Serrano-Aguilar P, Castells X, Quintana JM, Sala M, Redondo M; REDISSEC-CaMISS GroupI. Factors that Influence Treatment Delay for Patients with Breast Cancer. Ann Surg Oncol. 2021 Jul;28(7):3714-3721. Doi: 10.1245/s10434-020-09409-2.

2020

  • Louro J, Román M, Posso M, Comerma L, Vidal C, Saladié F, Alcántara R, Sánchez M, Quintana MJ, del Riego J, Ferrer J, Peñalva L, Bargalló X, Prieto M, Sala M, Castells X. Differences in breast cancer risk after benign breast disease by type of screening diagnosis. Breast. 2020. https://doi.org/10.1016/j.breast.2020.09.005
  • Escribà JM, Banqué M, Macià F, Gálvez J, Esteban L, Pareja L, Clèries R, Sanz X, Castells X, Borrás JM, Ribes J. Detection of incident breast and colorectal cancer cases from an administrative healthcare database in Catalonia, Spain. Clin Transl Oncol. 2020 Jun;22(6):943-952. Doi: 10.1007/s12094-019-02219-3
  • Alonso-Molero J, Dierssen-Sotos T, Gomez-Acebo I, Fernandez de Larrea Baz N, Guevara M, Amiano P, Castaño-Vinyals G, Fernandez-Villa T, Moreno V, Bayo J, Molina-Barceloa A, Fernández-Ortíz M, Suarez-Calleja C, Marcos-Gragera R, Castells X, Gil-Majuelo L, Ardanaz E, Pérez-Gómez B, Kogevinas M, Pollán M, Llorca J. Quality of Life in a Cohort of 1078 Women Diagnosed with Breast Cancer in Spain: 7-Year Follow-Up Results in the MCC-Spain Study. Int J Environ Res Public Health. 2020 Nov 13;17(22):8411. Doi: 10.3390/ijerph17228411. 
  • Schünemann HJ, Lerda D, Dimitrova N, Alonso-Coello P, Gräwingholt A, Quinn C, Follmann M, Mansel R, Sardanelli F, Rossi PG, Lebeau A, Nyström L, Broeders M, Ioannidou-Mouzaka L, Duffy SW, Borisch B, Fitzpatrick P, Hofvind S, Castells X, Giordano L, Warman S, Saz-Parkinson Z, European Commission Initiative on Breast Cancer Contributor Group. Methods for Development of the European Commission Initiative on Breast Cancer Guidelines: Recommendations in the Era of Guideline Transparency. Ann Intern Med 2020; 171(4): 273-280. Doi: 10.7326/M18-3445. 
  • Politi J, Sala M, Domingo L, Vernet-Tomas M, Román M, Macià F, Castells X. Readmissions and complications in breast ductal carcinoma in situ: A retrospective study comparing screen- and non-screen-detected patients. Womens Health (Lond). 2020 Jan-Dec;16:1745506520965899. Doi: 10.1177/1745506520965899. 
  • Jansana A, Del Cura I, Prados-Torres A, Sanz Cuesta T, Poblador-Plou B, Gimeno Miguel A, Lanzuela M, Ibañez B, Tamayo I, Moreno-Iribas C, Padilla-Ruiz M, Redondo M, Comas M, Domingo L, Díaz-Holgado A, Salamanca FJ, Castells X, Sala M; SURBCAN group. Use of real-world data to study health services utilisation and comorbidities in long-term breast cancer survivors (the SURBCAN study): study protocol for a longitudinal population-based cohort study. BMJ Open. 2020 Sep 9;10(9):e040253. Doi: 10.1136/bmjopen-2020-040253. 
  • Muratov S, Canelo-Aybar C, Tarride JE, Alonso-Coello P, Dimitrova N, Borisch B, Castells X, Duffy SW, Fitzpatrick P, Follmann M, Giordano L, Hofvind S, Lebeau A, Quinn C, Torresin A, Vialli C, Siesling S, Ponti A, Giorgi Rossi P, Schünemann H, Nyström L, Broeders M; ECIBC contributor group. Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators. BMC Cancer. 2020 Aug 24;20(1):795. Doi: 10.1186/s12885-020-07289-z. 
  • García EV, Sala M, Continente-Garcia X, Serral Cano, Puigpinós-Riera R. The association between breast cancer and consumption of dairy products: a systematic review. Nutr Hosp 2020; 34(3): 589-598. Doi: 10.20960/nh.02649
  • Puigpinós-Riera R, Serral G, Sala M, Bargalló X, Quintana MJ, Espinosa M, Manzanera R, Doménech M, Macià F, Grau J, Vidal E. Cancer-related fatigue and its determinants in a cohort of women with breast cancer: the DAMA Cohort. Support Care Cancer. 2020 Nov;28(11):5213-5221. Doi: 10.1007/s00520-020-05337-9. 
  • Gómez-Acebo I, Dierssen-Sotos T, Palazuelos C, Castaño-Vinyals G, Pérez-Gómez B, Amiano P, Fernández-Villa T, Ardanaz E, Suarez-Calleja C, Alguacil J, Molina-Barceló A, Jiménez-Moleón JJ, Molero JA, Roca-Barceló A, Chirlaque MD, Vázquez JPF, Molinuevo A, Aragonés N, Sala M, Binefa G, Moreno V, Pollán M, Kogevinas M, Llorca J. Changes in individual and contextual socio-economic level influence on reproductive behavior in Spanish women in the MCC-Spain study. BMC Womens Health. 2020 Apr 15;20(1):72. Doi: 10.1186/s12905-020-00936-4
  • Gómez-Acebo I*, Dierssen-Sotos T, Palazuelos-Calderón C, Pérez-Gómez B, Amiano P, Guevara M, Molina AJ, Domingo L, et al. Tumour characteristics and survivorship in a cohort of breast cancer: the MCC-Spain study.  Breast Cancer Res Tr 2020; 181(3): 667-678. Doi: 10.1007/s10549-020-05600-x

2019

  • Domingo L, Sala M, Louro J, Baré M, Barata T, Ferrer J, Carmona-Garcia MC, Comas M, Castells X, Camiss Study Group. Exploring the Role of Breast Density on Cancer Prognosis among Women Attending Population-Based Screening Programmes. J Oncol. 2019 Nov 27;2019:1781762. Doi: 10.1155/2019/1781762. 
  • Miret C, Domingo L, Louro J, Barata T, Baré M, Ferrer J, Carmona-García MC, Castells X, Sala M. Factors associated with readmissions in women participating in screening programs and treated for breast cancer: a retrospective cohort study. BMC Health Serv Res. 2019 Dec 5;19(1):940. Doi: 10.1186/s12913-019-4789-3. 
  • Natal C, Fernandez-Somoano A, Torá-Rocamora I, Vidal C, Castells X, Tardón A; Benign Lesion Study Group; Benign Lesion Study Group. Dissemination of Health technologies: Trends in the use of diagnostic test in breast cancer screening. J Healthc Qual Res. 2019 Jul-Aug;34(4):177-184. Doi: 10.1016/j.jhqr.2019.02.007. 
  • Zarcos-Pedrinaci I, Redondo M, Louro J, Rivas-Ruiz F, Téllez T, Pérez D, Medina Cano F, Machan K, Domingo L, Mar Vernet M, Padilla-Ruiz M, Castells X, Rueda A, Sala M; REDISSEC-CaMISS Group. Impact of adjuvant chemotherapy on the survival of patients with breast cancer diagnosed by screening. Cancer Med. 2019 Nov;8(15):6662-6670. Doi: 10.1002/cam4.2488. 
  • Jansana A, Posso M, Guerrero I, Prados-Torres A, Del Cura MI, Castells X, Sala M. Health care services use among long-term breast cancer survivors: a systematic review. J Cancer Surviv. 2019 Jun;13(3):477-493. Doi: 10.1007/s11764-019-00755-z. (Erratum in: J Cancer Surviv 2019 Jun;13(3):494). 
  • Pérez-Lacasta MJ, Martínez-Alonso M, Garcia M, Sala M, Perestelo-Pérez L, Vidal C, Codern-Bové N, Feijoo-Cid M, Toledo-Chávarri A, Cardona À, Pons A, Carles-Lavila M, Rue M; with the InforMa Group. Effect of information about the  benefits and harms of mammography on women’s decision making: The InforMa randomised controlled trial. PLoS One. 2019 Mar 26;14(3):e0214057. Doi: 10.1371/journal.pone.0214057. 
  • Aguirre U, García-Gutiérrez S, Romero A, Domingo L, Castells X, Sala M; CAMISS Study Group. External validation of the PREDICT tool in Spanish women with breast cancer participating in population-based screening programmes. J Eval Clin Pract. 2019 Oct;25(5):873-880. Doi: 10.1111/jep.13084. 
  • Blay L, Louro J, Barata T, Baré M, Ferrer J, Abad JM, Castells X, Sala M. Variability of breast surgery in women participating in breast cancer screening programs. Cir Esp (Engl Ed). 2019 Feb;97(2):89-96. English, Spanish. Doi: 10.1016/j.ciresp.2018.11.001. 
  • Puigpinós-Riera R, Castillo Gómez A, Romero Morales A, Aller M, Castells X, Sala M; grupo Cohort Dama. Determinantes sociales y clínicos del uso de servicios sanitarios en mujeres con cáncer de mama (Cohorte DAMA) [Social and clinical determinants of the use of health services in women with breast cancer (Cohort DAMA)]. Gac Sanit. 2019 Sep-Oct;33(5):434-441. Doi: 10.1016/j.gaceta.2018.04.014. 
  • Román M, Sala M, Domingo L, Posso M, Louro J, Castells X. Personalized breast cancer screening strategies: A systematic review and quality assessment. PLoS ONE. 2019; 14(12): e0226352. https://doi.org/10.1371/journal.pone.0226352
  • Román M, Sala M, Baré M, Posso M, Vidal C, Louro J, Sánchez M, Peñalva L, Castells X, on behalf of the BELE study group. Changes in mammographic density over time and the risk of breast cancer: an observational cohort study. Breast. 2019; 46:108-115. https://doi.org/10.1016/j.breast.2019.04.007.
  • Posso M, Louro J, Sánchez M, Román M, Vidal C, Sala M, Baré M, Castells X; BELE study group. Mammographic breast density: How it affects performance indicators in screening programmes?. Eur J Radiol. 2019; 110:81-87. Doi: 10.1016/j.ejrad.2018.11.012.
  • Louro J, Posso M, Boon MH, Román M, Domingo L, Castells X, Sala M. A systematic review and quality assessment of individualised breast cancer risk prediction models. Br J Cancer. 2019; Doi: 10.1038/s41416-019-0476-8.
  • Román M, Hofvind S, von Euler-Chelpin M, Castells X. Long-term risk of screen-detected and interval breast cancer after false-positive results at mammography screening: Joint analysis of three national cohorts. Br J Cancer. 2019; 120(2):269-275. Doi: 10.1038/s41416-018-0358-5.